RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 66 filers reported holding RA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $14,190,000 | +18.0% | 600,000 | +50.0% | 0.04% | +16.7% |
| Q2 2019 | $12,028,000 | +53.4% | 400,000 | +14.3% | 0.03% | +50.0% |
| Q1 2019 | $7,840,000 | +115.4% | 350,000 | +75.0% | 0.02% | +100.0% |
| Q4 2018 | $3,640,000 | +266.6% | 200,000 | +194.1% | 0.01% | +400.0% |
| Q3 2017 | $993,000 | -53.9% | 68,000 | -40.9% | 0.00% | -60.0% |
| Q2 2017 | $2,155,000 | -28.2% | 115,000 | -18.4% | 0.01% | -37.5% |
| Q1 2017 | $3,002,000 | +12.9% | 141,000 | -19.4% | 0.01% | +14.3% |
| Q4 2016 | $2,658,000 | – | 175,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|